PA2G4 and breast carcinoma: Given the divergent results and considering previous studies showing that overexpression of EBP1 p42 can inhibit the proliferation of breast cancer cells [19], we speculate that the differential roles of the two EBP1 subunits may contribute to their varied effects in different tumors.